Lixte Biotechnology Holdings (LIXT) Stock Overview

Develops utility-scale mobile energy storage systems on providing transportable solutions. More details

LIXT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

LIXT Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW494,503 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

494,503 investors already sharing narratives

View all narratives

Lixte Biotechnology Holdings, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Lixte Biotechnology Holdings
Historical stock prices
Current Share Price	US$7.21
52 Week High	US$7.99
52 Week Low	US$7.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	LIXT	US Electrical	US Market
7D	n/a	0.4%	1.6%
1Y	n/a	62.3%	18.6%

Return vs Industry: Insufficient data to determine how LIXT performed against the US Electrical industry.

Return vs Market: Insufficient data to determine how LIXT performed against the US Market.

Price Volatility

Is LIXT's price volatile compared to industry and market?
LIXT volatility
LIXT Average Weekly Movement	n/a
Electrical Industry Average Movement	12.6%
Market Average Movement	7.3%
10% most volatile stocks in US Market	16.7%
10% least volatile stocks in US Market	3.2%

Stable Share Price: LIXT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine LIXT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	John Travaglini	www.nomadpower.com

Lixte Biotechnology Holdings, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions. It offers plug-and-play battery storage systems integrated into specially designed and patent-pending mobile energy storage systems and docking systems. The company’s products include Traveler, a mobile battery energy storage system offering utility-scale power with 1 MW output and 2 MWh capacity; Voyager Falcon, an energy storage system for peak shaving, load shifting, and renewable integration projects; Voyager Eagle, a battery storage solution for rapid response grid services and demanding industrial applications; and Voyager Hawk, a battery storage solution for construction sites, events, and emergency backup.

Lixte Biotechnology Holdings, Inc. Fundamentals Summary

How do Lixte Biotechnology Holdings's earnings and revenue compare to its market cap?
LIXT fundamental statistics
Market cap	US$125.36m
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is LIXT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LIXT income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did LIXT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/04 00:14
End of Day Share Price	2026/07/02 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lixte Biotechnology Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Lixte Biotechnology Holdings, Inc.NasdaqCM:LIXT Stock Report